189 related articles for article (PubMed ID: 37548315)
1. The Harmonising Outcome Measures for Eczema (HOME) implementation roadmap.
Leshem YA; Simpson EL; Apfelbacher C; Spuls PI; Thomas KS; Schmitt J; Howells L; Gerbens LAA; Jacobson ME; Katoh N; Williams HC
Br J Dermatol; 2023 Nov; 189(6):710-718. PubMed ID: 37548315
[TBL] [Abstract][Full Text] [Related]
2. Implementation of the HOME core outcome set for clinical trials of atopic eczema-barriers and opportunities: the HOME IX meeting report.
Jacobson ME; Thomas KS; Apfelbacher CJ; Leshem YA; Williams HC; Gerbens LAA; Spuls PI; Schmitt J; Howells L; Katoh N; Simpson EL;
Arch Dermatol Res; 2023 Nov; 315(9):2617-2622. PubMed ID: 37432466
[TBL] [Abstract][Full Text] [Related]
3. The Harmonizing Outcome Measures for Eczema (HOME) roadmap: a methodological framework to develop core sets of outcome measurements in dermatology.
Schmitt J; Apfelbacher C; Spuls PI; Thomas KS; Simpson EL; Furue M; Chalmers J; Williams HC
J Invest Dermatol; 2015 Jan; 135(1):24-30. PubMed ID: 25186228
[TBL] [Abstract][Full Text] [Related]
4. How to use the Harmonising Outcome Measures for Eczema Core Outcome Set for atopic dermatitis trials: a users' guide.
Thomas KS; Howells L; Leshem YA; Simpson EL; Apfelbacher C; Spuls PI; Gerbens LAA; Jacobson ME; Katoh N; Williams HC; Stuart BL
Br J Dermatol; 2024 Mar; 190(4):527-535. PubMed ID: 38123134
[TBL] [Abstract][Full Text] [Related]
5. A protocol for developing, disseminating, and implementing a core outcome set (COS) for childbirth pelvic floor trauma research.
Doumouchtsis SK; Rada MP; Pergialiotis V; Falconi G; Haddad JM; Betschart C
BMC Pregnancy Childbirth; 2020 Jun; 20(1):376. PubMed ID: 32591018
[TBL] [Abstract][Full Text] [Related]
6. Vitiligo International Task force for an Agreed List of core data (VITAL): study protocol of a vitiligo core outcome set (COS) and contextual factors for clinical trials, registries, and clinical practice.
van Geel N; Hamzavi IH; Pandya AG; Wolkerstorfer A; Seneschal J; Garg A; Spuls P; Terwee CB; Mallett S; Speeckaert R; Meurant JM; Eleftheriadou V; Ezzedine K
Trials; 2022 Jul; 23(1):591. PubMed ID: 35871019
[TBL] [Abstract][Full Text] [Related]
7. A protocol for the Development of Core Outcome Sets for Endodontic Treatment modalities (COSET): an international consensus process.
El Karim IA; Duncan HF; Cushley S; Nagendrababu V; Kirkevang LL; Kruse C; Chong BS; Shah PK; Lappin M; McLister C; Lundy FT; Clarke M
Trials; 2021 Nov; 22(1):812. PubMed ID: 34789318
[TBL] [Abstract][Full Text] [Related]
8. Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials: a Harmonising Outcome Measures for Eczema (HOME) statement.
Spuls PI; Gerbens LAA; Simpson E; Apfelbacher CJ; Chalmers JR; Thomas KS; Prinsen CAC; von Kobyletzki LB; Singh JA; Williams HC; Schmitt J;
Br J Dermatol; 2017 Apr; 176(4):979-984. PubMed ID: 27858989
[TBL] [Abstract][Full Text] [Related]
9. Protocol for the development of an international Core Outcome Set for treatment trials in adults with epilepsy: the EPilepsy outcome Set for Effectiveness Trials Project (EPSET).
Mitchell JW; Noble A; Baker G; Batchelor R; Brigo F; Christensen J; French J; Gil-Nagel A; Guekht A; Jette N; Kälviäinen R; Leach JP; Maguire M; O'Brien T; Rosenow F; Ryvlin P; Tittensor P; Tripathi M; Trinka E; Wiebe S; Williamson PR; Marson T
Trials; 2022 Nov; 23(1):943. PubMed ID: 36397081
[TBL] [Abstract][Full Text] [Related]
10. coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials.
Tambor E; Robinson M; Hsu L; Chang HY; Al Naber J;
BMC Med Res Methodol; 2021 Oct; 21(1):219. PubMed ID: 34666680
[TBL] [Abstract][Full Text] [Related]
11. Developing a core outcome set for people living with dementia at home in their neighbourhoods and communities: study protocol for use in the evaluation of non-pharmacological community-based health and social care interventions.
Harding AJE; Morbey H; Ahmed F; Opdebeeck C; Wang YY; Williamson P; Swarbrick C; Leroi I; Challis D; Davies L; Reeves D; Holland F; Hann M; Hellström I; Hydén LC; Burns A; Keady J; Reilly S
Trials; 2018 Apr; 19(1):247. PubMed ID: 29690920
[TBL] [Abstract][Full Text] [Related]
12. Relevant domains, core outcome sets and measurements for implant dentistry clinical trials: The Implant Dentistry Core Outcome Set and Measurement (ID-COSM) international consensus report.
Tonetti MS; Sanz M; Avila-Ortiz G; Berglundh T; Cairo F; Derks J; Figuero E; Graziani F; Guerra F; Heitz-Mayfield L; Jung RE; Lai H; Needleman I; Papapanou PN; Sailer I; Sanz-Sanchez I; Schwarz F; Shi J; Thoma D
Clin Oral Implants Res; 2023 May; 34 Suppl 25():4-21. PubMed ID: 37232121
[TBL] [Abstract][Full Text] [Related]
13. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
14. Reaching clinically relevant outcome measures for new pharmacotherapy and immunotherapy of atopic eczema.
Chalmers J; Deckert S; Schmitt J;
Curr Opin Allergy Clin Immunol; 2015 Jun; 15(3):227-33. PubMed ID: 26153875
[TBL] [Abstract][Full Text] [Related]
15. Development of reporting guidance and core outcome sets for seamless, standardised evaluation of innovative surgical procedures and devices: a study protocol for content generation and a Delphi consensus process (COHESIVE study).
Avery K; Blazeby J; Wilson N; Macefield R; Cousins S; Main B; Blencowe NS; Zahra J; Elliott D; Hinchliffe R; Potter S
BMJ Open; 2019 Sep; 9(9):e029574. PubMed ID: 31515426
[TBL] [Abstract][Full Text] [Related]
16. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
[TBL] [Abstract][Full Text] [Related]
17. Study protocol: a core outcome set for perinatal interventions for congenital diaphragmatic hernia.
Vergote S; De Bie F; Bosteels J; Hedrick H; Duffy J; Power B; Benachi A; De Coppi P; Fernandes C; Lally K; Reiss I; Deprest J
Trials; 2021 Feb; 22(1):158. PubMed ID: 33622390
[TBL] [Abstract][Full Text] [Related]
18. Development of a Core outcome set for fetal Myelomeningocele (COSMiC): study protocol.
Altoukhi S; Whitehead CL; Ryan G; Deprest J; Joyeux L; Gallagher K; Drake J; Church P; Horn D; Diambomba Y; Carvalho JCA; Van Mieghem T
Trials; 2020 Aug; 21(1):732. PubMed ID: 32825852
[TBL] [Abstract][Full Text] [Related]
19. Development of an international core outcome set for treatment trials in necrotizing enterocolitis-a study protocol.
Klerk DH; van Varsseveld OC; Offringa M; Modi N; Lacher M; Zani A; Pakarinen MP; Koivusalo A; Jester I; Spruce M; Derikx JPM; Bakx R; Ksia A; Vermeulen MJ; Kooi EMW; Hulscher JBF
Trials; 2023 May; 24(1):367. PubMed ID: 37259112
[TBL] [Abstract][Full Text] [Related]
20. COSUMO: study protocol for the development of a core outcome set for efficacy and effectiveness trials in posterior segment-involving uveitis.
Tallouzi MO; Mathers JM; Moore DJ; Murray PI; Bucknall N; Blazeby JM; Calvert M; Denniston AK
Trials; 2017 Dec; 18(1):576. PubMed ID: 29191216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
